Reaction
Pharyngeal Ulceration reporting signals
As of the last recalculation, Pharyngeal Ulceration appears in 1,311 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 25.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Thiotepa | 15 | 25.2 | 25.3 |
| Nystatin Ointment | 29 | 17.9 | 18.0 |
| Nystatin Cream | 29 | 17.9 | 17.9 |
| Nystatin | 29 | 17.2 | 17.2 |
| Cabozantinib | 44 | 15.0 | 15.0 |
| Regorafenib | 8 | 11.0 | 11.0 |
| Niraparib | 13 | 9.4 | 9.4 |
| Sorafenib | 11 | 8.5 | 8.5 |
| Fludarabine Phosphate | 20 | 8.2 | 8.2 |
| Alpelisib | 4 | 7.3 | 7.3 |
| Asenapine Maleate | 3 | 5.5 | 5.5 |
| Bimekizumab | 4 | 3.0 | 3.0 |
| Nirmatrelvir And Ritonavir | 8 | 2.4 | 2.4 |